New Insights Into Alzheimer’s Development by Scientists

Summary of Scientists Reveal New Insights Into the Development of Alzheimer’s Disease:
Researchers from the University of Leipzig, Monash University in Australia, the Leibniz Institute of Surface Engineering and the University of Göttingen have published a study examining the association between oxidised cell membranes and peptide aggregation, which is thought to be behind Alzheimer’s disease. The scientists combined biophysical laboratory experiments and computer simulations to understand peptide aggregation and found that some peptides aggregated faster in the presence of all membranes while another peptide’s aggregation was completely prevented in the presence of oxidised membranes. The researchers used model systems that are easy to control experimentally to study the influence of oxidising processes on the chemical composition of membranes.

*****
Introduction: Understanding Alzheimer’s and the Search for a Cure

Alzheimer’s is a progressive neurodegenerative disease that affects memory, thinking, and behavior. It is the most common cause of dementia, which is a general term for a decline in cognitive ability that interferes with daily life. There is currently no cure for Alzheimer’s, but scientists are actively researching ways to better understand and treat this disease.

Oxidative Stress and Peptide Aggregation

One theory for the development of Alzheimer’s is the accumulation of peptides in the brain, also known as “clumping.” However, stress has also been suspected as a potential trigger for the disease. The University of Leipzig, Monash University in Australia, the Leibniz Institute of Surface Engineering (IOM), and the University of Göttingen collaborated to study the association between oxidized cell membranes and peptide aggregation. The results of their research have been published in the journal Chemical Science.

Studying the Impact of Oxidative Stress on Peptide Aggregation

The researchers wanted to better understand how cell membranes in the body influence the structure of peptides – these are molecules made up of amino acids – and their aggregation. To do this, they used model systems that are easy to control experimentally. They combined both biophysical laboratory experiments and computer simulations to better understand peptide aggregation.

Dr. Torsten John, the first author of the study, explains: “One of the effects of stress in the body is that it leads to oxidative processes and thus changes the chemical composition of membranes. In our experiments, we compared the effects of oxidized membranes with those that were not changed.”

The Role of Membrane Composition in Peptide Aggregation

It was already known that the composition of cell membranes plays an important role in peptide aggregation. However, there has been little research into the role of oxidized membranes. The researchers found that the effects differ between peptides. One of the peptides studied (Aβ40), which is associated with Alzheimer’s disease, aggregated faster in the presence of all membranes. In contrast, the aggregation of another peptide (uperin 3.5) was completely prevented in the presence of the same amount of oxidized membranes.

Professor Abel explains: “Depending on the peptide’s properties, including its charge, its attraction to the membrane changes, and thus the strength of the influence. If the peptides accumulate on the membrane surface, this accelerates their assembly and aggregation. However, if the attraction is very strong and they change their structure into a helix, then they can no longer aggregate.”

Studying Peptides with Different Origins

The scientists deliberately chose peptides for their study that aggregate similarly but have a different origin. Aβ40 is known to be deposited in the brains of people with Alzheimer’s disease, whereas uperin 3.5 is an antimicrobial peptide first discovered in an Australian toad species. Previously, the team of researchers led by Professor Lisandra L. Martin of Monash University in Australia reported on possible links between peptide aggregation in neurodegenerative diseases and the antimicrobial properties of peptides.

Conclusion: Advancing Our Understanding of Alzheimer’s Disease

The research conducted by the University of Leipzig, Monash University, the Leibniz Institute of Surface Engineering, and the University of Göttingen has shed new light on the role of oxidative stress in the development of Alzheimer’s disease. By studying the impact of oxidized cell membranes on peptide aggregation, the researchers have gained valuable insights into the molecular mechanisms underlying the disease.

While there is currently no cure for Alzheimer’s, continued research into the disease is essential for advancing our understanding of its underlying mechanisms and developing better treatments. The findings of this study provide a roadmap for future research on the role of oxidative stress in neurodegenerative diseases and provide hope for the millions of people affected by Alzheimer’s worldwide.

Read the Source Here